Exclusive Interview with Global Head of Maternal & Paediatric Regulatory Policy, Novartis

LONDON - Feb. 11, 2014 - PRLog -- SMi invites you to attend the 8th annual Paediatric Clinical Trials (http://www.smi-online.co.uk/goto/2014paediatric-trials.asp?emref=P-099ER10000023&amp) conference, taking place in London on 31st March and 1st April 2014.

We are very grateful to our keynote speaker, Christina Bucci-Rechtweg, Head of Maternal & Paediatric Regulatory Policy from Novartis, for taking time out to give us her views on the biggest challenge for paediatric drug development, opportunity for global harmonisation of paediatric clinical trial regulation and lessons learned from the FDASIA case study.

“A more cohesive international regulatory collaboration would be expected to lead to minimization of duplicative or unnecessary studies and foster innovation in both the technical and clinical development realms to address the unmet medical needs of children”

To read the full interview you can visit the download centre at http://www.smi-online.co.uk/goto/2014paediatric-trials41.asp

Christina will be joined at the event by Novartis Global Scientific Affairs Senior Expert, David McIntosh, who will be presenting on vaccine trials verses antibiotic trials. When asked about his upcoming presentation, David commented:

“The talk on Vaccine Trials Versus Antibiotic Trials will discuss the pros and cons of prevention versus cure, providing examples of the role of vaccines in decreasing antibiotic resistance. Key randomised controlled vaccine trials will be discussed and contrasted with key antibiotic trials – the risk of failure will also be highlighted.”

To hear more about the fundamental aspects of Paediatric Clinical Trials with senior decision makers from the industry, those interested can register to attend the event at http://www.smi-online.co.uk/goto/2014paediatric-trials41.asp

PAEDIATRIC CLINICAL TRIALS
31st March - 1st April 2014
The Kensington Close Hotel
London UK
http://www.paediatric-trials.co.uk